SCHEMBL23769032

SCHEMBL23769032

O=C(Nc1ccc2c(c1)OCC(=O)N2Cc1cccnc1)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.42
ITGA2B P08514 4/20 0.42
TP53 P04637 2/20 0.42
ATR Q13535 1/20 0.42
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.41
CDK8 P49336 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ROCK2 O75116 2/20 0.41
USP2 O75604 3/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23769094 0.90 CDK8 (0.47) ITGB3ITGA2BALDH1A1POLBCDK8
SCHEMBL23769073 0.89 ITGB3 (0.51) ITGB3ITGA2BCDK8TDP1
SCHEMBL29979318 0.89 ITGB3 (0.51) ITGB3ITGA2BCDK8TDP1
SCHEMBL23768811 0.86 ROCK2 (0.41) ITGB3ITGA2BTP53ATRCDK8
SCHEMBL29979350 0.86 NLRP3 (0.45) ITGB3ITGA2BTDP1
SCHEMBL29979311 0.86 ITGB3 (0.43) ITGB3ITGA2BTDP1
SCHEMBL23768812 0.86 ITGB3 (0.43) ITGB3ITGA2BTDP1
SCHEMBL23769388 0.86 NLRP3 (0.45) ITGB3ITGA2BTDP1
SCHEMBL23769385 0.85 ITGB3 (0.45) ITGB3ITGA2BPOLB
SCHEMBL25138340 0.85 ITGB3 (0.45) ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS ITGB3 2071/4885ITGA2B 839/4885TP53 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.